LECTIN DELIVERY VEHICLE TARGETING TO DESTROY TUMOR GROWTH THROUGH SPECIFICALLY BINDING TO CARBOHYDRATE MOTIFS ON CANCER CELLS

摘要

The present invention provides a novel therapeutic lectin distinguish difference in carbohydrate profiles between normal and tumor tissues. The invention also provides for the use of Bid BH3 glycomimetic-induced release of cytochrome c and cell death in cancer cells. Additionally, the invention provides the use of magnetic drug targeting to treat malignant tumors loco-regionally without systemic toxicity.